Skip to main content
Log in

Childhood-onset psoriatic onychopachydermo-periostitis treated successfully with infliximab

  • Correspondence
  • Published:
European Journal of Dermatology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fournié B, Viraben R, Durroux R, Lassoued S, Gay R, Fournié A. [Psoriatic onycho-pachydermo-periostitis of the big toe. Anatomoclinical study and physiopathogenic approach apropos of 4 cases]. Rev Rhum Mal Osteoartic 1989; 56: 579–82.

    PubMed  Google Scholar 

  2. Fietta P, Manganelli P. Childhood onset of psoriatic onychopachydermo-periostitis (POPP). J Eur Acad Dermatol Venereol 2005; 19: 780–2.

    Article  PubMed  CAS  Google Scholar 

  3. Bethapudi S, Halstead J, Ash Z, McGonagle D, Grainger AJ. Test yourself: psoriatic onycho-pachydermo periostitis (POPP). Skeletal Radiol 2014; 43, 409-11: 373–4.

    Article  Google Scholar 

  4. Boisseau-Garsaud AM, Beylot-Barry M, Doutre MS, Beylot C, Baran R. Psoriatic onycho-pachydermo-periostitis. A variant of psoriatic distal interphalangeal arthritis? Arch Dermatol 1996; 132: 176–80.

    Article  PubMed  CAS  Google Scholar 

  5. Ochiai T, Washio H, Shiraiwa H, Takei M, Sawada S. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate. Med Sci Monit 2006; 12: CS27–30.

    PubMed  Google Scholar 

  6. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol 2009; 23(Suppl 1): 9–13.

    Article  PubMed  CAS  Google Scholar 

  7. Bongartz T, Härle P, Friedrich S, et al. Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab. Arthritis Rheum 2005; 52: 280–2.

    Article  PubMed  CAS  Google Scholar 

  8. Kapusta MA, Dumont C. Differential response of psoriatic onychopachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents. J Rheumatol 2008; 35: 2077–80.

    PubMed  Google Scholar 

  9. Dans M, Hivnor C, van Voorhees AS. Psoriatic onychopachydermoperiostitis: improvement with etanercept. Br J Dermatol 2005; 153: 858–9.

    Article  PubMed  CAS  Google Scholar 

  10. Gerloni V, Pontikaki I, Gattinara M, Fantini F. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Ann Rheum Dis 2008; 67: 1145–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daisuke Watabe.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watabe, D., Endoh, K., Maeda, F. et al. Childhood-onset psoriatic onychopachydermo-periostitis treated successfully with infliximab. Eur J Dermatol 25, 506–508 (2015). https://doi.org/10.1684/ejd.2015.2616

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2015.2616

Keywords

Navigation